Letters by company
RaySearch Laboratories AB (publ)
4 letters discussing RSLBF. Everything written about it on this site is on its ticker page.
- Protean Funds Wide Confidence Intervals Protean Funds argues that position sizing should assume investors will sometimes be confidently wrong, after profit warnings at RaySearch and Devyser. Small Cap added to Devyser, rebuilt MT Højgaard and increased real-estate exposure while trimming Truecaller. Select traded Evolution, shorted Industrivärden and added to its Novo Nordisk short after the ZEUS readout. July 2026 DVYSR $89MEVGGF $15BNVO $168B
- Protean Funds How to believe in impossible things Protean Select argues that AI adoption in Europe faces underpriced political and regulatory friction, pairing longs in perceived AI losers with shorts in richly valued beneficiaries. Protean Small Cap added Indutrade and Truecaller, joined the Nordtech, Savox and Tången IPOs, sold Viva Wine and CINT after bids, and initiated Skanska while maintaining a short in Telia. June 2026 IDDWF $9.6BNTECH SKSBF $11B
- Protean Funds Protean Small Cap celebrates a milestone Protean Small Cap reviews its three-year portfolio, arguing that contrarian entry points and active turnover produced winners such as Acast while narrative-driven small caps also created costly mistakes. The fund added Octave for its cash-generative software business, restored Truecaller after an operational trough, and joined Biomar's IPO on improving fish-feed pricing power. Protean Select closed to new subscriptions after crossing its assets threshold. May 2026 ACAST $581MBMKDF $36MOCTV $5.3B
- Protean Funds Previously Unseen Levels Of Monitoring The Situation Protean Funds added selectively to Nordic small-cap holdings after pension-fund restructuring created forced selling, while reducing Select exposure and ending its EUR and DKK hedge. Small Cap sold Lundbeck, Asmodee, Kambi and Xano, and added Coffee Stain, Sinch and MTG while trimming Smartoptics. February 2026 7806 $2.3BACAST $581MARFA $63M
